Inhaled GM-CSF in a Pulmonary Alveolar Proteinosis Patient Refractory to Plasmapheresis Combined with Multiple Whole Lung Lavages

Journal Title: Archives of Pulmonology and Respiratory Care - Year 2017, Vol 3, Issue 1

Abstract

A autoimmune Pulmonary Alveolar Proteinosis (PAP) patient with persistent disease underwent 3 Whole Lung Lavages (WLLs), 10 plasmapheresis sessions and further 3 WLL, from October 2004 to May 2007. Nevertheless HRTC and pulmonary function test (PFT) showed a persistent residual disease of mild degree. At the beginning of 2010, the patient was admitted to inhaled rGM-CSF (Sargramostim) therapy as compassionate treatment. GM-CSF was administered by Akita 2 nebulizer (Vectura), as follow: 250 mcg/day every other week for 12 weeks, then 250 mcg/day on 2 consecutive days every 2 weeks for 6 months. Follow up visits were scheduled at 3, 10, 18, 30 months and after that once a year. Functional and HRCT data and PaO2 were collected. Since the start of the inhaled GM-CSF therapy, the patient no more required WLL. Furthermore we found a significant increase in DLCO% (p=0.013) and FVC% (p=0.023) while %FEV1 show a positive trend. No substantial differences in blood gas analysis. The pulmonary involvement at HRCT shows a significant decrease of lung infiltrates (p=0.039) in terms of pathological segments. These data underscore the utility of inhaled GM-CSF not only in case of progressing disease but also in case of refractory patients with persistent lung infiltrates, in order to increase the response rate.

Authors and Affiliations

Mariani Francesca, Paracchini Elena, Piloni Davide, Kadija Zamir, Salvaterra Elena, Divizia Laura, Rodi Giuseppe, Tinelli Carmine, Meloni Federica, Campo Ilaria

Keywords

Related Articles

Ticarcillin Hypersusceptibility in Pseudomonas Aeruginosa in Cystic Fibrosis

Background: A subpopulation of Pseudomonas aeruginosa (PsA) exists in cystic fibrosis (CF) patients that is hypersusceptible to ticarcillin, a carboxypenicillin, in vitro (Tichs strain) defined as a minimum inhibitory co...

Asthma Attacks During Pregnancy in the ICU: Just Be Alert

Background: Asthma represents one of the most common medical conditions encountered during pregnancy, which may seriously affect its outcome. Objective: To evaluate the outcome of asthma attacks during pregnancy and the...

The Endoscopic Treatment of Tracheo-bronchial Amyloidosis: A Challenging Issue

Tracheo-bronchial amyloidosis is a rare airway disorder that can be a challenge for the limitations of treatment, recurrence and complications. We report the complex clinical course of a patient with symptomatic localize...

Hypoxia/Reoxygenation modulates Oxidative Stress Level and Antioxidative Potential in Lung Mitochondria: Possible participation of P53 and NF-KB Target Proteins

Background and objective: Hypoxia/reoxygenation (H/R) is a key factor in the pathogenesis of the most lung diseases where exсessive ROS production and prooxidant/antioxidant imbalance greatly contribute to disease progre...

Different Levels of Exhaled Nasal Nitric Oxide in Patients Diagnosed with Primary Dyskinesia

Background: Primary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormally beating cilia. In these patients levels of nasal nitric oxide (nNO) are lower than those observed in healthy subjects. Obje...

Download PDF file
  • EP ID EP340762
  • DOI 10.17352/aprc.000018
  • Views 60
  • Downloads 0

How To Cite

Mariani Francesca, Paracchini Elena, Piloni Davide, Kadija Zamir, Salvaterra Elena, Divizia Laura, Rodi Giuseppe, Tinelli Carmine, Meloni Federica, Campo Ilaria (2017). Inhaled GM-CSF in a Pulmonary Alveolar Proteinosis Patient Refractory to Plasmapheresis Combined with Multiple Whole Lung Lavages. Archives of Pulmonology and Respiratory Care, 3(1), 16-19. https://europub.co.uk/articles/-A-340762